Global Irritable Bowel Syndrome (IBS) Market Growth 2019-2024

  • ID:PD040813
  • January 2019
  • LPI (LP Information)
                          

The Global Irritable Bowel Syndrome (IBS) Market Research Report available with DecisionDatabases.com explores the market statistics between 2019 to 2024. The historic data of Irritable Bowel Syndrome (IBS) market size, market share, revenue, consumption, sales has been gathered, analysed and compiled in this report assuring high quality and precision. The future trends are explored under the guidance of industry experts and analysts. The forecast trends and Irritable Bowel Syndrome (IBS) industry outlook will assist opportunists with ideal information and data to take an informed decision.

Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. The disorder is classified into three main subtypes, according to the predominant bowel habits presented: constipation-predominant IBS (IBS-C), diarrhea-predominant IBS (IBS-D), and mixed-presentation IBS (IBS-M). IBS is among the most common gastrointestinal disorders, with an estimated pooled international IBS prevalence rate of about 11.2%.

Currently, the IBS treatment market is naïve and underpenetrated, with 4 products indicated for IBS in the market. These include the IBS-C therapies, Amitiza (lubiprostone, Sucampo/Takeda) and Linzess (linaclotide, Ironwood/Allergan/Astellas); and the IBS-D therapies, Lotronex (Sebela Pharmaceuticals) and Irribow (ramosetron, Astellas). Antidepressants and antibiotics (mainly Xifaxan [rifaximin], Valeant) are also used off-label to treat IBS.

The IBS treatment market is characterized by significant unmet needs, which include the need for products with improved efficacy, products for the treatment of the IBS-D and IBS-M subtypes, and products that effectively address IBS symptoms, such as abdominal pain and bloating, as well as the requirement for the improved diagnosis of IBS. As a result, there are significant opportunities in the uncrowded IBS therapeutics market.

According to this study, over the next five years the Irritable Bowel Syndrome (IBS) market will register a 16.3% CAGR in terms of revenue, the global market size will reach US$ 6530 million by 2024, from US$ 2640 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Irritable Bowel Syndrome (IBS) business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Irritable Bowel Syndrome (IBS) market by product type, application, key manufacturers and key regions and countries.

This study considers the Irritable Bowel Syndrome (IBS) value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.

  •  IBS-D Drug
  •  IBS-C Drug
  •  Other
 
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
  •  Women
  •  Men

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
  •  Americas
  •  United States
  •  Canada
  •  Mexico
  •  Brazil
  •  APAC
  •  China
  •  Japan
  •  Korea
  •  Southeast Asia
  •  India
  •  Australia
  •  Europe
  •  Germany
  •  France
  •  UK
  •  Italy
  •  Russia
  •  Spain
  •  Middle East & Africa
  •  Egypt
  •  South Africa
  •  Israel
  •  Turkey
  •  GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
  •  Allergan
  •  Valeant Pharmaceuticals
  •  Takeda
  •  Sucampo Pharmaceuticals
  •  McNeil Consumer Healthcare
  •  Sebela Pharmaceuticals
  •  Astellas Pharmaceuticals
  •  IM HealthScience

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
  •  To study and analyze the global Irritable Bowel Syndrome (IBS) consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
  •  To understand the structure of Irritable Bowel Syndrome (IBS) market by identifying its various subsegments.
  •  Focuses on the key global Irritable Bowel Syndrome (IBS) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
  •  To analyze the Irritable Bowel Syndrome (IBS) with respect to individual growth trends, future prospects, and their contribution to the total market.
  •  To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
  •  To project the consumption of Irritable Bowel Syndrome (IBS) submarkets, with respect to key regions (along with their respective key countries).
  •  To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
  •  To strategically profile the key players and comprehensively analyze their growth strategies.

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
 
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Irritable Bowel Syndrome (IBS) Consumption 2014-2024
2.1.2 Irritable Bowel Syndrome (IBS) Consumption CAGR by Region
2.2 Irritable Bowel Syndrome (IBS) Segment by Type
2.2.1 IBS-D Drug
2.2.2 IBS-C Drug
2.2.3 Other
2.3 Irritable Bowel Syndrome (IBS) Consumption by Type
2.3.1 Global Irritable Bowel Syndrome (IBS) Consumption Market Share by Type (2014-2019)
2.3.2 Global Irritable Bowel Syndrome (IBS) Revenue and Market Share by Type (2014-2019)
2.3.3 Global Irritable Bowel Syndrome (IBS) Sale Price by Type (2014-2019)
2.4 Irritable Bowel Syndrome (IBS) Segment by Application
2.4.1 Women
2.4.2 Men
2.5 Irritable Bowel Syndrome (IBS) Consumption by Application
2.5.1 Global Irritable Bowel Syndrome (IBS) Consumption Market Share by Application (2014-2019)
2.5.2 Global Irritable Bowel Syndrome (IBS) Value and Market Share by Application (2014-2019)
2.5.3 Global Irritable Bowel Syndrome (IBS) Sale Price by Application (2014-2019)
 
3 Global Irritable Bowel Syndrome (IBS) by Players
3.1 Global Irritable Bowel Syndrome (IBS) Sales Market Share by Players
3.1.1 Global Irritable Bowel Syndrome (IBS) Sales by Players (2017-2019)
3.1.2 Global Irritable Bowel Syndrome (IBS) Sales Market Share by Players (2017-2019)
3.2 Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Players
3.2.1 Global Irritable Bowel Syndrome (IBS) Revenue by Players (2017-2019)
3.2.2 Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Players (2017-2019)
3.3 Global Irritable Bowel Syndrome (IBS) Sale Price by Players
3.4 Global Irritable Bowel Syndrome (IBS) Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Irritable Bowel Syndrome (IBS) Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Irritable Bowel Syndrome (IBS) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
 
4 Irritable Bowel Syndrome (IBS) by Regions
4.1 Irritable Bowel Syndrome (IBS) by Regions
4.1.1 Global Irritable Bowel Syndrome (IBS) Consumption by Regions
4.1.2 Global Irritable Bowel Syndrome (IBS) Value by Regions
4.2 Americas Irritable Bowel Syndrome (IBS) Consumption Growth
4.3 APAC Irritable Bowel Syndrome (IBS) Consumption Growth
4.4 Europe Irritable Bowel Syndrome (IBS) Consumption Growth
4.5 Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption Growth
 
5 Americas
5.1 Americas Irritable Bowel Syndrome (IBS) Consumption by Countries
5.1.1 Americas Irritable Bowel Syndrome (IBS) Consumption by Countries (2014-2019)
5.1.2 Americas Irritable Bowel Syndrome (IBS) Value by Countries (2014-2019)
5.2 Americas Irritable Bowel Syndrome (IBS) Consumption by Type
5.3 Americas Irritable Bowel Syndrome (IBS) Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
 
6 APAC
6.1 APAC Irritable Bowel Syndrome (IBS) Consumption by Countries
6.1.1 APAC Irritable Bowel Syndrome (IBS) Consumption by Countries (2014-2019)
6.1.2 APAC Irritable Bowel Syndrome (IBS) Value by Countries (2014-2019)
6.2 APAC Irritable Bowel Syndrome (IBS) Consumption by Type
6.3 APAC Irritable Bowel Syndrome (IBS) Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
 
7 Europe
7.1 Europe Irritable Bowel Syndrome (IBS) by Countries
7.1.1 Europe Irritable Bowel Syndrome (IBS) Consumption by Countries (2014-2019)
7.1.2 Europe Irritable Bowel Syndrome (IBS) Value by Countries (2014-2019)
7.2 Europe Irritable Bowel Syndrome (IBS) Consumption by Type
7.3 Europe Irritable Bowel Syndrome (IBS) Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
 
8 Middle East & Africa
8.1 Middle East & Africa Irritable Bowel Syndrome (IBS) by Countries
8.1.1 Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption by Countries (2014-2019)
8.1.2 Middle East & Africa Irritable Bowel Syndrome (IBS) Value by Countries (2014-2019)
8.2 Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption by Type
8.3 Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
 
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
 
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Irritable Bowel Syndrome (IBS) Distributors
10.3 Irritable Bowel Syndrome (IBS) Customer
 
11 Global Irritable Bowel Syndrome (IBS) Market Forecast
11.1 Global Irritable Bowel Syndrome (IBS) Consumption Forecast (2019-2024)
11.2 Global Irritable Bowel Syndrome (IBS) Forecast by Regions
11.2.1 Global Irritable Bowel Syndrome (IBS) Forecast by Regions (2019-2024)
11.2.2 Global Irritable Bowel Syndrome (IBS) Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Irritable Bowel Syndrome (IBS) Forecast by Type
11.8 Global Irritable Bowel Syndrome (IBS) Forecast by Application
 
12 Key Players Analysis
12.1 Allergan
12.1.1 Company Details
12.1.2 Irritable Bowel Syndrome (IBS) Product Offered
12.1.3 Allergan Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 Allergan News
12.2 Valeant Pharmaceuticals
12.2.1 Company Details
12.2.2 Irritable Bowel Syndrome (IBS) Product Offered
12.2.3 Valeant Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 Valeant Pharmaceuticals News
12.3 Takeda
12.3.1 Company Details
12.3.2 Irritable Bowel Syndrome (IBS) Product Offered
12.3.3 Takeda Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 Takeda News
12.4 Sucampo Pharmaceuticals
12.4.1 Company Details
12.4.2 Irritable Bowel Syndrome (IBS) Product Offered
12.4.3 Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 Sucampo Pharmaceuticals News
12.5 McNeil Consumer Healthcare
12.5.1 Company Details
12.5.2 Irritable Bowel Syndrome (IBS) Product Offered
12.5.3 McNeil Consumer Healthcare Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 McNeil Consumer Healthcare News
12.6 Sebela Pharmaceuticals
12.6.1 Company Details
12.6.2 Irritable Bowel Syndrome (IBS) Product Offered
12.6.3 Sebela Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 Sebela Pharmaceuticals News
12.7 Astellas Pharmaceuticals
12.7.1 Company Details
12.7.2 Irritable Bowel Syndrome (IBS) Product Offered
12.7.3 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2017-2019)
12.7.4 Main Business Overview
12.7.5 Astellas Pharmaceuticals News
12.8 IM HealthScience
12.8.1 Company Details
12.8.2 Irritable Bowel Syndrome (IBS) Product Offered
12.8.3 IM HealthScience Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2017-2019)
12.8.4 Main Business Overview
12.8.5 IM HealthScience News
 
13 Research Findings and Conclusion

Related Categories
Pharmaceuticals
Related Reports
Global Tigecycline Market Research Report 2017

The Global Tigecycline Market Research Report provides a detailed market overview along with the analysis of industry’s gross margin, cost  read more..


Global Caffeine Market Research Report 2017

The Global Caffeine Market Research Report provides a detailed market overview along with the analysis of industry’s gross margin, cost structure,  read more..


Global Rabies Vaccine Market Research Report 2017

The Global Rabies Vaccine Market Research Report provides a detailed market overview along with the analysis of industry’s gross margin, cost  read more..


United States Parkinsons Disease Drug Market Report 2018-2025

The United States Parkinsons Disease Drug market research report is the study prepared by analysts, which contain a detailed analysis of drivers,  read more..


Global Radiopharmaceuticals Market Research Report 2019

The Global Radiopharmaceuticals market report is a recent research added by DecisionDatabases.com, offers critical insight into the Market dynamic. This  read more..


Global Neurorehabilitation System Market Research Report

Neurorehabilitation system is as innovative technological solution to monitor and review the activity of nervous systems. It is a relatively new method  read more..


Global Molecular Biology Kits And Reagents Market Research Report

The global molecular biology kits and reagents market is expected to grow at a CAGR of ~7% from 2013 to 2018. A number of factors such as rise in  read more..


Global High Acuity Care Information Systems Market Research Report

The global high acuity care information systems market is expected to grow at a CAGR of ~4% from 2013 to 2018. A number of factors such as growing focus  read more..


Global Regenerative Medicine Market Research Report

The global regenerative medicine market was estimated to be at ~$4.5 billion in 2013.   A number of factors such as increasing bone related  read more..


Global Skin Cancer Diagnostics Market Research Report

Cancers of skin tissues are one of the major types of cancers in the world. In recent years, more than 40% of all cancers in the U.S. have been skin  read more..